0001022079-20-000063.txt : 20200228
0001022079-20-000063.hdr.sgml : 20200228
20200228175301
ACCESSION NUMBER: 0001022079-20-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E
CENTRAL INDEX KEY: 0001222679
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 20672920
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_158293036468118.xml
FORM 4
X0306
4
2020-02-26
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222679
PREVOZNIK MICHAEL E
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
SVP & General Counsel
Common Stock
2020-02-26
4
S
0
321
111.09
D
41445
D
Common Stock
2020-02-26
4
F
0
668
112.90
D
40777
D
Common Stock
2020-02-27
4
S
0
690
109.02
D
40087
D
Common Stock
5105
I
401(k)/SDCP
The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 24, 2018.
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik
2020-02-28